Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AUNA Auna	$6.29 -0.4%	$6.29	$6.05 ▼ $9.24	$467.02M	2.25	22,608 shs	34,592 shs
CDNA CareDx	$12.51 +2.8%	$15.70	$10.96 ▼ $33.21	$647.77M	2.22	1.32 million shs	1.27 million shs
CSTL Castle Biosciences	$19.97 +1.0%	$18.70	$14.59 ▼ $35.84	$573.78M	1.09	702,908 shs	227,339 shs
DCGO DocGo	$1.60 -0.6%	$1.53	$1.23 ▼ $5.68	$157.47M	0.96	543,878 shs	299,308 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AUNA Auna	+0.08%	-0.47%	-0.90%	-7.14%	-16.86%
CDNA CareDx	+5.19%	+0.33%	-4.55%	-28.87%	-62.50%
CSTL Castle Biosciences	-0.60%	+1.91%	+18.30%	+24.48%	-26.77%
DCGO DocGo	+1.26%	-6.94%	+13.38%	+20.15%	-54.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AUNA Auna	4.4073 of 5 stars	3.2	4.0	0.0	3.2	0.0	3.8
CDNA CareDx	4.1946 of 5 stars	3.3	2.0	4.2	2.1	0.8	1.9
CSTL Castle Biosciences	2.0361 of 5 stars	3.5	3.0	0.0	1.1	1.7	0.0
DCGO DocGo	2.1446 of 5 stars	3.3	3.0	0.0	1.8	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AUNA Auna	2.33	Hold	$10.70	70.25% Upside
CDNA CareDx	2.67	Moderate Buy	$27.67	121.16% Upside
CSTL Castle Biosciences	3.00	Buy	$37.00	85.28% Upside
DCGO DocGo	2.50	Moderate Buy	$3.59	124.38% Upside

Current Analyst Ratings Breakdown

Latest DCGO, CDNA, CSTL, and AUNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	DCGO DocGo	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$1.45 ➝ $1.60
8/8/2025	CDNA CareDx	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$19.00 ➝ $14.00
7/18/2025	CDNA CareDx	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $26.00
5/22/2025	AUNA Auna	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/22/2025	AUNA Auna	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Hold	$7.90
5/21/2025	CSTL Castle Biosciences	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Outperform ➝ Sector Outperform	$44.00 ➝ $40.00

(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AUNA Auna	$1.17B	0.40	$1.16 per share	5.40	$6.64 per share	0.95
CDNA CareDx	$333.79M	1.99	$1.40 per share	8.95	$6.15 per share	2.03
CSTL Castle Biosciences	$332.07M	1.74	$0.99 per share	20.10	$15.70 per share	1.27
DCGO DocGo	$616.55M	0.25	$0.42 per share	3.81	$2.94 per share	0.54

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AUNA Auna	$29.39M	$0.58	7.14	7.96	N/A	5.49%	15.14%	3.60%	N/A
CDNA CareDx	$52.55M	$1.02	12.26	N/A	N/A	17.97%	18.03%	12.88%	11/3/2025 (Estimated)
CSTL Castle Biosciences	$18.25M	-$0.35	56.51	N/A	N/A	-2.73%	2.37%	2.03%	11/3/2025 (Estimated)
DCGO DocGo	$19.99M	-$0.19	0.00	20.00	N/A	-4.20%	-3.26%	-2.24%	11/6/2025 (Estimated)

Latest DCGO, CDNA, CSTL, and AUNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2025	Q2 2025	AUNA Auna	$0.13	$0.33	+$0.20	$0.31	$1.17 billion	$309.00 million
8/7/2025	Q2 2025	DCGO DocGo	-$0.06	-$0.11	-$0.05	-$0.11	$77.58 million	$80.42 million
8/6/2025	Q2 2025	CDNA CareDx	$0.12	-$0.16	-$0.28	-$0.16	$90.72 million	$90.51 million
8/4/2025	Q2 2025	CSTL Castle Biosciences	-$0.51	$0.15	+$0.66	$0.15	$71.53 million	$86.18 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AUNA Auna	N/A	N/A	N/A	N/A	N/A
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
CSTL Castle Biosciences	N/A	N/A	N/A	N/A	N/A
DCGO DocGo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AUNA Auna	1.71	0.91	0.78
CDNA CareDx	N/A	3.30	3.00
CSTL Castle Biosciences	0.02	6.85	6.69
DCGO DocGo	N/A	2.36	2.36

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AUNA Auna	N/A
CDNA CareDx	N/A
CSTL Castle Biosciences	92.60%
DCGO DocGo	56.44%

Insider Ownership

Company	Insider Ownership
AUNA Auna	N/A
CDNA CareDx	4.40%
CSTL Castle Biosciences	6.50%
DCGO DocGo	3.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AUNA Auna	14,842	74.01 million	N/A	N/A
CDNA CareDx	740	53.23 million	50.89 million	Optionable
CSTL Castle Biosciences	540	29.01 million	27.12 million	Optionable
DCGO DocGo	4,407	97.81 million	94.09 million	Optionable

DCGO, CDNA, CSTL, and AUNA Headlines

Recent News About These Companies

DocGo Announces Participation at Three Upcoming Conferences

August 18 at 7:44 AM | finance.yahoo.com

DocGo Announces Participation at Three Upcoming Conferences

August 18 at 7:35 AM | businesswire.com

What is Northland Capmk's Estimate for DocGo Q3 Earnings?

August 15, 2025 | americanbankingnews.com

Northland Capmk Has Pessimistic Outlook of DocGo Q3 Earnings

August 14, 2025 | marketbeat.com

What is Northland Capmk's Estimate for DocGo Q2 Earnings?

August 14, 2025 | americanbankingnews.com

Q2 Earnings Estimate for DocGo Issued By Northland Capmk

August 13, 2025 | marketbeat.com

DocGo, Inc. Earnings Call: A Mixed Bag of Progress and Challenges

August 13, 2025 | msn.com

DocGo reports Q2 EPS (11c), consensus (23c)

August 9, 2025 | msn.com

DocGo Announces Second Quarter 2025 Results

August 9, 2025 | finance.yahoo.com

DocGo Inc. (DCGO) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

DocGo (DCGO) Q2 Revenue Falls 51%

August 8, 2025 | fool.com

DocGo Inc. (DCGO) Reports Q2 Loss, Beats Revenue Estimates

August 7, 2025 | zacks.com

DocGo to Provide Digital Transportation Management Platform, Dedicated Ambulance Service to Major New York Health System

August 6, 2025 | businesswire.com

DocGo Inc. (NASDAQ: DCGO) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims, $4 Million in Stock Sales

August 4, 2025 | prnewswire.com

Jefferies Financial Group Inc. Purchases 2,000,356 Shares of DocGo Inc. (NASDAQ:DCGO)

August 3, 2025 | marketbeat.com

Victory Capital Management Inc. Purchases 314,838 Shares of DocGo Inc. (NASDAQ:DCGO)

August 1, 2025 | marketbeat.com

DocGo Launches Mobile Health Vaccination Program for the County of San Diego

July 31, 2025 | businesswire.com

DocGo (DCGO) Expected to Announce Earnings on Thursday

July 31, 2025 | marketbeat.com

DocGo Inc. (NASDAQ:DCGO) Receives Average Rating of "Moderate Buy" from Brokerages

July 28, 2025 | marketbeat.com

DocGo to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

July 24, 2025 | businesswire.com

1492 Capital Management LLC Has $1.75 Million Holdings in DocGo Inc. (NASDAQ:DCGO)

July 24, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO, CDNA, CSTL, and AUNA Company Descriptions

Auna NYSE:AUNA

$6.28 -0.03 (-0.40%)

Closing price 03:59 PM Eastern

Extended Trading

$6.28 0.00 (-0.08%)

As of 06:38 PM Eastern

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

CareDx NASDAQ:CDNA

$12.51 +0.34 (+2.79%)

Closing price 04:00 PM Eastern

Extended Trading

$12.49 -0.02 (-0.17%)

As of 07:36 PM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Castle Biosciences NASDAQ:CSTL

$19.97 +0.19 (+0.96%)

Closing price 04:00 PM Eastern

Extended Trading

$19.60 -0.37 (-1.85%)

As of 07:56 PM Eastern

Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

DocGo NASDAQ:DCGO

$1.60 -0.01 (-0.62%)

Closing price 04:00 PM Eastern

Extended Trading

$1.60 0.00 (0.00%)

As of 07:51 PM Eastern

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time